McKinney JD, H?ner zu Bentrup K, Mu?oz-Elias EJ, et al. Persistence of mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase[J]. Nature, 2000, 406：735-738.
[2]
Flynn JL, Chan J. Tuberculosis：Latency and reactivation[J]. Infect Immun, 2001, 69（7）：4195-4201.
[3]
Ulrichs T, Kaufmann SH. Mycobacterial persistence and immunity[J]. Front Biosci, 2002, 7：458-469.
[4]
Yin Y, Niu X, Wu C, et al. Screening peptide inhibitors using phage peptide library with isocitrate lyase in mycobacterium tuberculosis as target[J]. Chem Res Chinese Universities, 2011, 27（4）：1-6.
Wei Z, Zhang H, Cui W, et al. Molecular docking and 3D-QSAR on maleimide derivatives as glycogen synthase kinase-3β inhibitors[J]. Acta Physico-Chimica Sinica, 2009, 25（5）：890-896.
[8]
Venkatachalam CM, Jiang X, Oldfield T, et al. Lig and fit：A novel method for the shape-directed rapid docking of ligands to protein active sites[J]. Journal of Molecular Graphics and Modelling, 2003, 21（4）：289-307.
[9]
Kumar M, Khan IA, Verma V, et al. Rapid, inexpensive MIC deter-mination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay[J]. Diagnostic Microbiology & Infectious Disease, 2005, 53（2）：121-124.
[10]
Vilchèze C, Hartman T, Weinrick B, Jacobs WR Jr. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a Vc-induced Fenton reaction[J]. Nature, 2013, 521：1-9.
Greene JG, Sheu SS, Gross RA, Greenamyre JT. 3-Nitropropionic acid exacerbates N-methy-D-aspartate toxicity in striatal culture by multiple mechanisms[J]. Neuroscience, 1998, 84（2）：503-510.
[13]
Ko YH, Smith BL, Wang Y, et al. Advanced cancers：eradication in all cases using 3-bromopyruvate therapy to deplete ATP[J]. Biochem Biophys Res Commun, 2004, 324（1）：269-275.
[14]
Liu X, Zang Y, Yin Y, et al. Optimization of phage heptapeptide library screening process for developing inhibitors of the isocitrate lyase homologue from Mycobacterium tuberculosis[J]. Med Chen Res, 2014, 23：2543-2553.
